2 ml vial of tirzepatide Is dosage correct? Tirzepatide / Niacinamide Injection |

Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Soliqua Patients naive to basal insulin or a GLP-1 agonist, currently on a GLP-1 agonist or less than 30 units of basal insulin daily: starting dose is 15 units once daily Patients currently on 30 to 60 units of basal insulin daily, with or without a GLP-1 agonist: starting dose is 30 units once daily Maintenance: titrate dose up or down by 2 - 4 units every week based on blood sugar goals Missed doses: resume dosing at the next scheduled dose

doi:10.1111/dom.14725 Academy of Nutrition and Dietetics

By understanding their individual benefits and potential synergies, individuals can make informed choices that align with their health goals

Keywords: incretins, type 2 diabetes, coagonists, GLP1, GIP, body weight Introduction Obesity and type 2 diabetes (T2D) remain epidemic problems